{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:41:43Z","timestamp":1760330503949,"version":"build-2065373602"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To explore the relationship between polycystic ovary syndrome with insulin resistance (PCOS-IR) and gut microbiota by analyzing the composition characteristics of gut microbiota in PCOS without or with Insulin resistance (IR) and the changes before and after treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Women with PCOS were recruited and divided into polycystic ovary syndrome without insulin resistance (PCOS-NIR) group and PCOS-IR group. The PCOS-NIR group was given oral drospirenone and ethinylestradiol tablets (II), and the PCOS-IR group was given oral drospirenone and ethinylestradiol tablets (II) combined with metformin hydrochloride tablets. The course of treatment was 3 months. Baseline data, blood and stool samples were collected before and after treatment. All those stool samples were used for 16S rDNA sequencing to analyze the composition of gut microbiota in each group and their correlation with biochemical parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1. Baseline data and biochemical parameters: before treatment, body mass index (BMI) in PCOS-NIR group was less than that in PCOS-IR group(<jats:italic>P<\/jats:italic> &amp;lt; 0.05). After treatment, CHO levels decreased in PCOS-NIR group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05); FINS, LDL-C and HOMA-IR decreased and HDL-C levels increased in PCOS-IR group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). 2. Characteristics of gut microbiota: before treatment, there was no significant difference in \u03b1 and \u03b2 diversity between PCOS-NIR group and PCOS-IR group. The gut microbiota both of the two groups were mainly composed of <jats:italic>Firmicutes<\/jats:italic>, <jats:italic>Fusobacteriia, Acidimicrobiia, Oscillospirales, Lachnospiracea, Ruminococcaceae<\/jats:italic>. The relative abundance of <jats:italic>Acidimicrobiia<\/jats:italic> in PCOS-IR group was higher than that in PCOS-NIR group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). The relative abundance of <jats:italic>Fusobacteriu<\/jats:italic> in the PCOS-IR group was lower than that before treatment (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). 3. Correlation between gut microbiota and biochemical parameters: before treatment, <jats:italic>Acidimicrobiia<\/jats:italic> was positively correlated with TG level in the PCOS-NIR group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05); <jats:italic>Acidimicrobiia<\/jats:italic> was positively correlated with HOMA-IR in the PCOS-IR group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). After treatment, <jats:italic>Fusobacterium<\/jats:italic> in PCOS-IR group was negatively correlated with HDL-C level (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>1. There is a difference in the relative abundance of <jats:italic>Acidimicrobiia<\/jats:italic> in the gut between PCOS-NIR and PCOS-IR patients before treatment, which is positively correlated with HOMA-IR, suggesting that <jats:italic>Acidimicrobiia<\/jats:italic> may be involved in the occurrence of PCOS-IR. 2. Drospirenone and ethinylestradiol tablets (II) combined with metformin tablets can change the gut microbiota relative abundance of patients with PCOS-IR, which may be related to the improvement of host lipid and glucose metabolism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1581504","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:16:59Z","timestamp":1760329019000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of drospirenone and ethinylestradiol tablets (II) combined with metformin on the composition of gut microbiota in polycystic ovary syndrome with insulin resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanglu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.3390\/jcm12206446","article-title":"Depression in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"12","author":"Dybciak","year":"2023","journal-title":"Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.999813","article-title":"Role of polycystic ovarian syndrome in developing psychological burden in Saudi Arabian females: A case control study","volume":"10","author":"Alamri","year":"2022","journal-title":"Front Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.1958310","article-title":"Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments","volume":"37","author":"Coll\u00e9e","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"B4","article-title":"Advances in the pathogenesis of polycystic ovary syndrome related infertility","volume":"29","author":"Chu","year":"2020","journal-title":"Adv Modern Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S0003","DOI":"10.1016\/j.ando.2023.06.001","article-title":"Cardio-metabolic risk in Rotterdam clinicalphenotypes of PCOS","volume":"84","author":"Mitra","year":"2023","journal-title":"Ann d'endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1515\/ijamh-2022-0065","article-title":"Depression and anxiety in adolescents and young women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"35","author":"Nasiri-Amiri","year":"2023","journal-title":"Adolesc Med Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2012.01458.x","article-title":"The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism","volume":"91","author":"Glintborg","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B8","article-title":"The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern","volume":"97","author":"Prakansamut","year":"2014","journal-title":"Med Assoc Thailand"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000067719","article-title":"Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome","volume":"54","author":"Bjercke","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"B10","article-title":"Polycystic ovarian disease","volume-title":"StatPearls","author":"Rasquin","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"7","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"B12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/MOP.0000000000000945","article-title":"Current concepts of polycystic ovary syndrome pathogenesis","volume":"32","author":"Rosenfield","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.08.003","article-title":"Insulin resistance in polycystic ovary syndrome: concept versus cutoff","volume":"12","author":"Greenwood","year":"2019","journal-title":"Fertil Steril"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13860","article-title":"Prevalence and degree of insulin resistance in Chinese Han women with PCOS: Results from euglycemic-hyperinsulinemic clamps","volume":"90","author":"Li","year":"2019","journal-title":"Clin Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cen.14895","article-title":"Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta-analysis and systematic review of randomized controlled trials","volume":"99","author":"Wu","year":"2023","journal-title":"Clin Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1135","article-title":"Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg","year":"2014","journal-title":"Clin Endocrinol Metab"},{"key":"B17","article-title":"Effect of drospirenone and ethinylestradiol tablets in the treatment of hyperandrogenism in polycystic ovary syndrome","volume":"39","author":"Xian","year":"2021","journal-title":"J Guangdong Med Univ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.02.024","article-title":"Gut microbiota, a new frontier to understand traditional Chinese medicines","volume":"142","author":"Feng","year":"2019","journal-title":"Pharmacol Res"},{"key":"B19","article-title":"Effects of metformin combined with Yousiyue on androgen and insulin levels in overweight or obese PCOS patients","volume":"7","author":"Hong","year":"2021","journal-title":"Smart Health"},{"key":"B20","article-title":"The effect of Yousiyuan combined with metformin in the treatment of obese polycystic ovary syndrome and its influence on serum Asprosin level and glucose and lipid metabolism","volume":"41","author":"Zhi","year":"2021","journal-title":"Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10\u201315","DOI":"10.1016\/j.ejogrb.2022.02.034","article-title":"New insights into polycystic ovary syndrome (PCOS) in adolescents","volume":"273","author":"Oberfield","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B22","first-page":"1","article-title":"Analysis of domestic and foreign guidelines or consensus on the treatment of polycystic ovary syndrome","volume":"5","author":"Bei","year":"2023","journal-title":"Zhonghua Tradit Chin Med"},{"key":"B23","article-title":"Interpretation of Chinese guidelines for diagnosis and treatment of polycystic ovary syndrome","volume":"34","author":"Yin","year":"2018","journal-title":"J Pract Obstet Gynecol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1039\/D1FO04387K","article-title":"Lactobacillus reuteri J1 prevents obesity by altering the gut microbiota and regulating bile acid metabolism in obese mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Food Funct"},{"key":"B26","doi-asserted-by":"publisher","first-page":"101493","DOI":"10.1016\/j.beem.2021.101493","article-title":"Gut microbiome and bile acids in obesity-related diseases","volume":"35","author":"Li","year":"2021","journal-title":"Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2019.1657515","article-title":"A new approach to polycystic ovary syndrome: the gut microbiota","volume":"39","author":"Yurtda","year":"2020","journal-title":"Am Coll Nutr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02653","article-title":"Fecal microbiota transplantation: A potential tool for treatment of human female reproductive tract diseases","volume":"26","author":"Quaranta","year":"2019","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/09513590.2021.2003325","article-title":"Menichini Daniela, Ughetti Claudia. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature","volume":"38","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.04.030","article-title":"Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish cohort study","volume":"145","author":"Palm","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07317-z","article-title":"Effect of insulin resistance on recurrence after radiofrequency catheter ablation in patients with atrial fibrillation","volume":"37","author":"Wang","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2307\/2531532","article-title":"Estimating the population size for capture-recapture data with unequal catchability","volume":"43","author":"Chao","year":"1987","journal-title":"Biometrics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2010.133","article-title":"UniFrac: an effective distance metric for microbial community comparison","volume":"169","author":"Lozupone","year":"2011","journal-title":"ISME J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"Ovarian Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2021.05.005","article-title":"Gut microbes and health","volume":"44","author":"\u00c1lvarez","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"B38","article-title":"Chinese expert consensus on the management of women with polycystic ovary syndrome before, during and after pregnancy(2023)","volume":"39","author":"Rong","year":"2023","journal-title":"Chin J Appl Gynecol Obstet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"B40","article-title":"Comparative analysis of clinical treatment of polycystic ovary syndrome with insulin resistance and non-insulin resistance","volume":"27","author":"Na","year":"2020","journal-title":"Capital Food Med"},{"key":"B41","article-title":"Clinical efficacy of drospirenone and ethinylestradiol combined with metformin in the treatment of polycystic ovary syndrome","volume":"15","author":"Liang","year":"2022","journal-title":"J Rational Use Drugs Clin Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"106370","DOI":"10.1016\/j.micpath.2023.106370","article-title":"Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: A systematic review and meta-analysis","volume":"184","author":"Zou","year":"2023","journal-title":"Microb Pathog"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e12734","DOI":"10.1111\/ijpo.12734","article-title":"Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments","volume":"16","author":"Garcia-Beltran","year":"2021","journal-title":"Pediatr Obes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e13417","DOI":"10.1111\/eci.13417","article-title":"Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population","volume":"51","author":"Mammadova","year":"2021","journal-title":"Clin Invest"},{"key":"B46","first-page":"001247","volume-title":"Analysis of intestinal flora in polycystic ovary syndrome patients with insulin resistance","author":"Hui","year":"2021"},{"key":"B47","first-page":"000847","volume-title":"Distribution of intestinal flora in patients with polycystic ovary syndrome and its changes before and after treatment","author":"Lian","year":"2021"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0160-1","article-title":"Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography","volume":"24","author":"Deschasaux","year":"2018","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13048-021-00799-9","article-title":"The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population","volume":"14","author":"He","year":"2021","journal-title":"Ovarian Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1039\/D1FO01744F","article-title":"Lactiplantibacillus plantarum CCFM1019 attenuate polycystic ovary syndrome through butyrate dependent gut-brain mechanism","volume":"13","author":"He","year":"2022","journal-title":"Food Funct"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6674965","article-title":"Effect of high-fat diet \u2009on \u2009the intestinal flora in letrozole-induced polycystic ovary syndrome rats","volume":"2021","author":"Zheng","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3390\/cells11193038","article-title":"Polycystic ovary syndrome and endometrial cancer: A scoping review of the literature on gut microbiota","volume":"11","author":"Prakash","year":"2022","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"15115","DOI":"10.1038\/s41598-022-19393-0","article-title":"Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan","volume":"12","author":"Kaiyrlykyzy","year":"2022","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmab004","article-title":"Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome","volume":"27","author":"de Medeiros","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2478\/prilozi-2020-0026","article-title":"Determination of the role of fusobacterium nucleatum in the pathogenesis in and out the mouth","volume":"41","author":"Tefiku","year":"2020","journal-title":"Pril (Makedon Akad Nauk Umet Odd Med Nauki)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.22074\/ijfs.2023.550187.1272","article-title":"Evaluation of microbial profile in patients with polycystic ovary syndrome and periodontal disease: A case-control study","volume":"17","author":"Achu Joseph","year":"2023","journal-title":"Fertil Steril"},{"key":"B59","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12916-023-02975-8","article-title":"Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"21","author":"Li","year":"2023","journal-title":"BMC"},{"key":"B60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13668-023-00451-6","article-title":"The effect on inflammation of adherence to the mediterranean diet in polycystic ovary syndrome","volume":"12","author":"\u00c7\u0131tar Daz\u0131ro\u011flu","year":"2023","journal-title":"Curr Nutr Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3390\/nu12072041","article-title":"Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: A randomised controlled pilot study","volume":"12","author":"Palacios","year":"2020","journal-title":"Nutrients"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2219342","DOI":"10.1080\/09513590.2023.2219342","article-title":"Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone","volume":"39","author":"Gan","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/19390211.2018.1455788","article-title":"The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: A triple-blind randomized controlled trial","volume":"16","author":"Rabiei","year":"2019","journal-title":"Diet Suppl"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2021.06.002","article-title":"Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blindplacebo-controlled trial","volume":"40","author":"Solito","year":"2021","journal-title":"Clin Nutr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1581504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:17:02Z","timestamp":1760329022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1581504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":64,"alternative-id":["10.3389\/fendo.2025.1581504"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1581504","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"article-number":"1581504"}}